Adherence to single-pill combination versus multiple-pill combination lipid-modifying therapy among patients with mixed dyslipidemia in a managed care population

By Kamat Siddhesh A.   Bullano Michael F.   Chang Chun-Lan   Gandhi Sanjay K.   Cziraky Mark J.  

Current Medical Research and Opinion, Vol. 27, Iss. 5, 2011-05 ,pp. : 961-968

Informa Healthcare

Access to resources Recommend Favorite

Lipid goals among patients with diabetes or metabolic syndrome: Lipid Treatment Assessment Project (L-TAP) 2

By Jukema J. Wouter   Chiang Cheng-Wen   Ferrières Jean   Santos Raul D.   Verdejo Juan   Waters David D.   Messig Michael   Tarasenko Lisa  

Current Medical Research and Opinion, Vol. 26, Iss. 11, 2010-11 ,pp. : 2589-2597

Informa Healthcare

Access to resources Recommend Favorite

Lipid-modifying effects of rosuvastatin in postmenopausal women with hypercholesterolemia who are receiving hormone replacement therapy

By Shepherd James   Packard Chris   Littlejohn Thomas W.   Walker James   Stein Evan A.   Smith Karen   Kallend David   Blasetto James W.  

Current Medical Research and Opinion, Vol. 20, Iss. 10, 2004-10 ,pp. : 1571-1578

Informa Healthcare

Access to resources Recommend Favorite

Effects of ezetimibe added to on-going statin therapy on the lipid profile of hypercholesterolemic patients with diabetes mellitus or metabolic syndrome

By Simons Leon   Tonkon Melvin   Masana Luis   Maccubbin Darbie   Shah Arvind   Lee Michael   Gumbiner Barry  

Current Medical Research and Opinion, Vol. 20, Iss. 9, 2004-09 ,pp. : 1437-1445

Informa Healthcare

Access to resources Recommend Favorite

New Advances in Lipid-Modifying Therapies for Reducing Cardiovascular Risk

By  

Cardiology, Vol. 97, Iss. 2, 2002-04 ,pp. : 59-66

Karger

Access to resources Recommend Favorite